RAPT Therapeutics
RAPT
RAPT was delisted on the 2nd of March, 2026.
105 hedge funds and large institutions have $1.02B invested in RAPT Therapeutics in 2025 Q4 according to their latest regulatory filings, with 49 funds opening new positions, 36 increasing their positions, 9 reducing their positions, and 8 closing their positions.
7,387% more call options, than puts
Call options by funds: $22.1M | Put options by funds: $295K
513% more first-time investments, than exits
New positions opened: 49 | Existing positions closed: 8
300% more repeat investments, than reductions
Existing positions increased: 36 | Existing positions reduced: 9
139% more capital invested
Capital invested by funds: $428M → $1.02B (+$594M)
62% more funds holding
Funds holding: 65 → 105 (+40)
9.04% more ownership
Funds ownership: 100.35% → 109.39% (+9%)
0% more funds holding in top 10
Funds holding in top 10: 9 → 9 (0)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
FIS
FCPM III Services
Naarden,
Netherlands
|
+$46.2M |
| 2 |
FLSM
Frazier Life Sciences Management
Palo Alto,
California
|
+$30.5M |
| 3 |
TCM
TCG Crossover Management
Palo Alto,
California
|
+$29.4M |
| 4 |
B
Braidwell
Stamford,
Connecticut
|
+$28.9M |
| 5 |
SL
Siren LLC
Greenwich,
Connecticut
|
+$24.7M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
DTC
Deep Track Capital
Greenwich,
Connecticut
|
-$19.9M |
| 2 |
BCM
Boone Capital Management
Atlanta,
Georgia
|
-$9.69M |
| 3 |
SC
SummitTX Capital
Fort Worth,
Texas
|
-$2.37M |
| 4 |
Ameriprise
Minneapolis,
Minnesota
|
-$1.33M |
| 5 |
Balyasny Asset Management
Chicago,
Illinois
|
-$1.3M |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
101
Royal Bank of Canada
Toronto,
Ontario, Canada
| $1K | -$448K | -14,419 | -100% |
|
102
Carson Wealth (CWM LLC)
Omaha,
Nebraska
| $1K | -$2.52K | -81 | -72% |
|
|
EWA
103
EverSource Wealth Advisors
Birmingham,
Alabama
| $678 | -$1.18K | -38 | -66% |
|
|
ACM
104
Aster Capital Management
Dubai,
United Arab Emirates
| $34 | +$31 | +1 | New |
|
|
SC
105
SummitTX Capital
Fort Worth,
Texas
| – | -$2.37M | -91,912 | Closed |
|
|
106
Ameriprise
Minneapolis,
Minnesota
| – | -$1.33M | -51,406 | Closed |
|
|
107
Balyasny Asset Management
Chicago,
Illinois
| – | -$1.3M | -50,348 | Closed |
|
|
SCM
108
Superstring Capital Management
New York
| – | -$888K | -34,449 | Closed |
|
|
TOCUITCONY
109
Trustees of Columbia University in the City of New York
New York
| – | -$237K | -9,172 | Closed |
|
110
Russell Investments Group
London,
United Kingdom
| – | -$27.9K | -1,080 | Closed |
|
|
BCV
111
Banque Cantonale Vaudoise
Lausanne,
Switzerland
| – | -$7K | -154 | Closed |
|
|
AAP
112
Arax Advisory Partners
Denver,
Colorado
| – | -$25 | -1 | Closed |
|
RAPT Hedge Fund Activity: Q4 2025 in Review
105 of the 8,224 institutional investors tracked by Wall St. Rank reported a position in RAPT Therapeutics (RAPT) for Q4 2025, worth a combined $1.02B — up 139% from $428M a quarter earlier.
Buyers outnumbered sellers: 49 funds opened new RAPT positions and 8 closed out — a net gain of 41 holders — while 36 added to existing stakes and 9 trimmed.
The largest buyer was FCPM III Services, adding an estimated $46.2M. The largest seller was Deep Track Capital, cutting an estimated $19.9M.
- 105 institutional investors held RAPT Therapeutics (RAPT) as of Q4 2025, up from 65 in Q3 2025.
- Funds reported $1.02B of RAPT Therapeutics stock for Q4 2025, up 139% quarter-over-quarter.
- 49 funds opened new RAPT Therapeutics positions in Q4 2025 and 8 closed out, a net change of +41 holders.
- The largest RAPT Therapeutics buyer in Q4 2025 was FCPM III Services, an estimated $46.2M added.
- The largest RAPT Therapeutics seller in Q4 2025 was Deep Track Capital, an estimated $19.9M sold.
Based on aggregated 13F filings for Q4 2025.